hero section gradient
15 handpicked stocks

Resource Nationalism Portfolio

This carefully selected collection features companies with strategic control over essential, finite resources in politically stable regions. As global demand for critical materials grows, these stocks offer a powerful defense against international supply chain disruptions.

Author avatar

Han Tan | Market Analyst

Published on June 17

Your Basket's Financial Footprint

Market capitalisation breakdown for the provided stock basket.

Key Takeaways for Investors:
  • Large-cap dominance generally implies greater stability and lower volatility, tracking broad market moves more closely.
  • Suitable as a core portfolio holding for diversified exposure, not primarily a speculative, high-growth allocation.
  • Expect steadier long-term appreciation rather than rapid, short-term gains; returns are likely more predictable.
Total Market Cap
  • MP: $13.12B

  • ALB: $10.75B

  • LAC: $1.14B

  • Other

About This Group of Stocks

1

Our Expert Thinking

This portfolio capitalizes on the growing value of essential resource control. Companies owning irreplaceable assets like lithium deposits, rare earths, copper reserves, and water rights in secure jurisdictions have built powerful competitive moats that insulate them from global volatility.

2

What You Need to Know

These companies operate in stable regions like the US, Canada, Australia, and Chile, minimizing political risks common in resource extraction. The portfolio offers exposure to tangible assets with long-term strategic value as nations increasingly prioritize domestic supply chain security.

3

Why These Stocks

Each company was selected for its dominant position controlling finite, critical resources essential for modern technology and infrastructure. With accelerating deglobalization trends and growing concerns about resource security, these firms are positioned to benefit from their strategic holdings.

Why You'll Want to Watch These Stocks

🌎

The New National Security Play

As countries race to secure domestic supply chains, these companies controlling vital resources in stable regions are becoming strategic national assets, potentially driving significant valuation premiums.

⛏️

Irreplaceable Assets

These companies own what others can't replicate: finite, geographically-fixed resources essential for modern technology and infrastructure. This creates a powerful competitive advantage as demand surges.

🔋

Powering the Green Revolution

Many of these companies control the critical minerals and materials essential for electric vehicles, renewable energy, and the entire clean technology ecosystem, positioning them at the heart of the energy transition.

Get the full story on this Basket. Read our detailed article on its risks and potential.

Read Full Insight

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Tech Stocks (AI Valuation Reset) Present Potential Entry

Tech Stocks (AI Valuation Reset) Present Potential Entry

Recent market turmoil, driven by concerns over AI stock valuations, has led to a significant drop in global markets. This correction creates a potential opportunity to invest in fundamentally sound technology companies at more attractive prices.

Walmart Succession Plan Explained | Market Effects

Walmart Succession Plan Explained | Market Effects

Walmart announced a CEO transition, with veteran John Furner taking the helm, which could create opportunities for competitors. This leadership change at a retail giant may cause short-term uncertainty, potentially benefiting other major players in the retail space.

Biotech Buyout Candidates (Post-Merck Acquisition)

Biotech Buyout Candidates (Post-Merck Acquisition)

Merck's $9.2 billion acquisition of Cidara Therapeutics for its antiviral drug pipeline signals a broader industry trend. This creates an investment opportunity in other biotech companies with promising late-stage drugs that could become the next acquisition targets for pharmaceutical giants.

Frequently Asked Questions